newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.

biotech / news / / Reuters

Amgen sells tarlatamab in its home market under the name Imdelltra.

Tarlatamab is a targeted immunotherapy for extensive-stage small cell lung cancer post-chemotherapy.

KEY POINTS
COMPANIES
Read the full story on Reuters →
Share X LinkedIn

Summarized by Newsio from Reuters. How we summarize →